CALD1 Modulates Gliomas Progression via Facilitating Tumor Angiogenesis

• Published in: Cancers Vol. 13; no. 11; p. 2705
• Main Authors: Cheng, Quan, Tang, Anliu, Wang, Zeyu, Fang, Ning, Zhang, Zhuojing, Zhang, Liyang, Li, Chuntao, Zeng, Yu
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 30.05.2021; MDPI
• Subjects: Algorithms; Angiogenesis; Antibodies; Astrocytoma; Calcium-binding protein; Calmodulin; Cell adhesion; Cell adhesion & migration; Cell migration; CRISPR; Cytoskeleton; Datasets; Endothelial cells; Gene expression; Genomes; Glioblastoma; Glioma; Immunofluorescence; Medical research; Microvasculature; Pericytes; Prognosis; Proteins; Sequence analysis; Stromal cells; Survival analysis; Tumor microenvironment; Vascularization; United States > US; China
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers13112705

Angiogenesis is more prominent in anaplastic gliomas and glioblastoma (GBM) than that in pilocytic and diffuse gliomas. Caldesmon (CALD1) plays roles in cell adhesion, cytoskeletal organization, and vascularization. However, limited information is available on mechanisms underlying the effect of CALD1 on the microvascular facilitation and architecture in glioma. In this study, we explored the role of CALD1 in gliomas by integrating bulk RNA-seq analysis and single cell RNA-seq analysis. A positive correlation between CALD1 expression and the gliomas’ pathological grade was noticed, according to the samples from the TCGA and CGGA database. Moreover, higher CALD1 expression samples showed worse clinical outcomes than lower CALD1 expression samples. Biofunction prediction suggested that CALD1 may affect glioma progression through modulating tumor angiogenesis. The map of the tumor microenvironment also depicted that more stromal cells, such as endothelial cells and pericytes, infiltrated in high CALD1 expression samples. CALD1 was found to be remarkably upregulated in neoplastic cells and was involved in tumorigenic processes of gliomas in single cell sequencing analysis. Histology and immunofluorescence analysis also indicated that CALD1 associates with vessel architecture, resulting in glioma grade progression. In conclusion, the present study implies that CALD1 may serve as putative marker monitoring the progress of glioma.